Literature DB >> 11667604

Carbene Rearrangements Unsurpassed: Details of the C(7)H(6) Potential Energy Surface Revealed.

Peter R. Schreiner1, William L. Karney, Paul von Ragué Schleyer, Weston Thatcher Borden, Tracy P. Hamilton, Henry F. Schaefer III.   

Abstract

The rearrangement of phenylcarbene (1) to 1,2,4,6-cycloheptatetraene (3) has been studied theoretically, using SCF, CASSCF, CASPT2N, DFT (B3LYP), CISD, CCSD, and CCSD(T) methods in conjunction with the 6-31G, 6-311+G, 6-311G(2d,p), cc-pVDZ, and DZd basis sets. Stationary points were characterized by vibrational frequency analyses at CASSCF(8,8)/6-31G and B3LYP/6-31G. Phenylcarbene (1) has a triplet ground state ((3)A") with a singlet-triplet separation (DeltaE(ST)) of 3-5 kcal mol(-)(1). In agreement with experiment, chiral 3 is the lowest lying structure on this part of the C(7)H(6) potential energy surface. Bicyclo[4.1.0]hepta-2,4,6-triene (2) is an intermediate in the rearrangement of 1 into 3, but it is unlikely to be observable experimentally due to a barrier height of only 1-2 kcal mol(-)(1). The enantiomers of 3 interconvert via the (1)A(2) state of cycloheptatrienylidene (4) with an activation energy of 20 kcal mol(-)(1). The "aromatic" (1)A(1) state, previously believed to be the lowest singlet state of 4, is roughly 10 kcal mol(-)(1) higher in energy than the (1)A(2) state, and, in violation of Hund's rule, (3)A(2) is also calculated to lie above (1)A(2) in energy. Thus, even if (3)A(2) were populated, it is likely to undergo rapid intersystem crossing to (1)A(2). We suggest (3)B(1)-4 is the metastable triplet observed by EPR.

Entities:  

Year:  1996        PMID: 11667604     DOI: 10.1021/jo960884y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

Review 1.  Theory and practice of uncommon molecular electronic configurations.

Authors:  Ganna Gryn'ova; Michelle L Coote; Clemence Corminboeuf
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2015-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.